Fractyl Health, Inc. (GUTS) vs Oncolytics Biotech Inc. (ONCY)

A side-by-side comparison of Fractyl Health, Inc. and Oncolytics Biotech Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$60M
$4.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Oncolytics Biotech Inc. logo
ONCY
Oncolytics Biotech Inc.
$60M
$0.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GUTS vs ONCY

growth of $100 · dividends reinvested · last 3y
GUTS -97.0% (-69.1%/yr)ONCY -51.1% (-21.2%/yr)ONCY compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$3$49
GUTS ONCY

GUTS vs ONCY: by the numbers

  • •GUTS is the larger company ($60M vs $60M market cap).

Metrics side by side

Profitability

MetricGUTSONCY
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROIC-129.67%-1235.48%

Growth (annualized)

MetricGUTSONCY
Total return CAGR (5Y)N/A-21.00%

Go deeper

Full GUTS analysisFull ONCY analysisInteractive comparison tool

Dig into the metrics

Fractyl Health ROEOncolytics Biotech ROEFractyl Health operating marginOncolytics Biotech operating marginFractyl Health revenue growthOncolytics Biotech revenue growthFractyl Health free cash flowOncolytics Biotech free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.